Lihat Juga

• ArthroCartiGenea®-AR: A Mesenchymal stem cells Co-Cultured Chondrocytes Comprising Chondrogenic Autologous Treatment for patients with Osteoarthritis and large Cartilage defects on assessing the Clinical Impact of Approximations in Analytical Dose Calculations for Advanced Cell Therapy
  oleh: Grigoriadis Ioannis
  Terbitan: (2015)
• CartiGenea®-AC: An autologous suspension of ex vivo expanded cartilage cells of combined medium for autologous use based on an effective method for the optimization of ACT protocols using iterative reconstruction algorithms compared with patient data
  oleh: Grigoriadis Ioannis
  Terbitan: (2015)
• CartireGENEATM®-CP: A Mesenchymal stem cells enriched chondrocytes as a combinatorial Autologous Treatment for patients with cartilage defects. A choice of statistical methods for comparisons of dosimetric data in cartilopoietic therapies
  oleh: Grigoriadis Ioannis
  Terbitan: (2015)
• CartiGenea®-AC: A Mesenchymal stem cells enriched Autologous Chondrocytes for the Treatment of patients with cartilaginous defects on a New Drug-Cell Combinatory Effect Prediction Algorithm on the Cell Based on Chondro defects Gene Expression and Dose-Response Curve
  oleh: Grigoriadis Ioannis
  Terbitan: (2015)
• An in silico axisymmetric multistage model of linear biphasic mesenchymal stem cell and chondrocyte protein secreted-matrix interactions for the reconstruction of the dynamic mechanical environment of a time varying magnetic field expanded chondrocyte biphasic finite elemental model in articular cartilage for the evaluation of the ability of natural and synthetic scaffolds in providing an appropriate environment for growth and sustain of the chondrogenic capacity of de-differentiated of cartilage-derived L-lactic glycolic acid (PLGA) loaded chondrocytes for and then for autologous transplantations
  oleh: Grigoriadis Ioannis
  Terbitan: (2015)